P, G., L, M., L, S., R, T., A, B., E, A., & O, J. (2026). Cationic liposome-mediated intra-articular delivery of lorecivivint for osteoarthritis treatment. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 220, 114980. https://doi.org/10.1016/j.ejpb.2026.114980
Chicago Style (17th ed.) CitationP, Gonzalez-Fernandez, Morici L, Simula L, Takwa R, Benabdellah A, Allémann E, and Jordan O. "Cationic Liposome-mediated Intra-articular Delivery of Lorecivivint for Osteoarthritis Treatment." European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V 220 (2026): 114980. https://doi.org/10.1016/j.ejpb.2026.114980.
MLA (9th ed.) CitationP, Gonzalez-Fernandez, et al. "Cationic Liposome-mediated Intra-articular Delivery of Lorecivivint for Osteoarthritis Treatment." European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V, vol. 220, 2026, p. 114980, https://doi.org/10.1016/j.ejpb.2026.114980.